Experian (LSE:EXPN) Stock Could Still Be A Bargain After A 29% Rebound

Experian shares have rebounded over the past few years, which puts fresh attention on what investors are really paying for in terms of the company's cash generation. With new initiatives in healthcare data and credit analytics rolling out, the key question is whether the current price fairly reflects the cash flows those businesses can support.

• The stock has delivered a 28.7% gain over the past 3 years, which raises the issue of how much future cash flow strength is already embedded in the valuation.

• Experian Health's acquisition of eInsights and the integration of income and employment verification into patient financial clearance can shift the timing and resilience of cash flows from healthcare and credit decisioning clients.

• Prefer to judge Experian on earnings? See what Experian's 23.3x P/E says about the price .

The stock's next move may depend on whether Experian's current share price lines up with the intrinsic value suggested by its cash flows.

If you want to test the same cash flow question you are asking of Experian across a wider field, compare it with companies in the solid balance sheet and fundamentals stocks screener (9 results) .

Is Experian a Bargain on Cash Flow?

The Discounted Cash Flow (DCF) model here looks at what Experian's future cash generation could be worth in today's money. On the latest numbers, the group is producing last twelve month free cash flow of about US$1.5b, and the 2 Stage Free Cash Flow to Equity model assumes that this pool of cash continues to grow over time rather than shrink. That pattern of projected cash flows underpins the view that Experian's estimated intrinsic worth sits substantially above the current £29.86 share price.

Experian's healthcare and credit decisioning moves matter for this picture because they influence how resilient and repeatable those projected cash streams could be. The acquisition of eInsights, which targets missed reimbursements for hospitals and clinics, fits with a thesis that the business can keep turning data assets into cash in a steady way, because it deepens relationships with clients that care about dependable reimbursement. Because the DCF projections put Experian's estimated intrinsic value substantially above the current share price, the gap between the cash flow view and what the market is paying today is still material. Find out what Experian could be worth using our Discounted Cash Flow (DCF) estimate .

The Experian Narrative: What Would Justify Today's Price?

Simply Wall St Narratives pick up where Experian's cash flow puzzle leaves off and spell out which assumptions on future growth, margins and earnings would need to hold for the stock to warrant a materially higher or lower price than today, all housed on the Community page. Each one treats Experian's fair value as a thesis about how the business might develop that you can revisit over time, rather than a one-off snapshot.